Atherosclerotic CVD Benefits From Statins
For patients who have experienced an atherosclerotic cardiovascular disease event, receipt of statins, especially high-intensity statins, is associated with reduced risk of major adverse cardiac events.
Atherosclerosis
Canakinumab May Lower Lung Cancer Incidence in Patients With Atherosclerosis
Anti-inflammatory therapy with canakinumab may result in a significantly lower incidence of lung cancer and lung cancer mortality.
Intracranial Atherosclerotic Plaque Prevalence May Vary by Race
Black men have increased prevalence and frequency of multiple intracranial atherosclerotic plaques.
Effect of Exercise on Coronary Artery Calcification
White males who participate in 3 times the recommended physical activity over many years have higher odds of developing coronary subclinical atherosclerosis.
Reduced Forced Vital Capacity May Be Useful for Risk Assessment of Arterial Stiffness
Restrictive spirometry pattern and reduced forced vital capacity level are associated with increased risk of arterial stiffness.
Sudden Death Most Common Cause of CV Death in Diabetes and Atherosclerotic CVD
Sudden death is the most common category of cardiovascular mortality among patients with type 2 diabetes and atherosclerotic CVD.
Coronary Artery Calcium Useful in Predicting Cardiovascular Risk in COPD
Coronary artery calcium may be the best noninvasive risk marker for predicting a major cardiovascular event in patients with COPD.
Factors Associated With Accelerated Atherosclerosis in Spondyloarthritis Without Overt CVD
Certain factors have been associated with accelerated atherosclerosis in spondyloarthritis without overt cardiovascular disease.
Atherosclerosis Risk Increased When Skipping Breakfast
Habitual skipping of breakfast is associated with increased likelihood of atherosclerosis independent of traditional and dietary cardiovascular risk factors.
Anacetrapib Reduces Major Coronary Events When Added to Intensive Statin Therapy
Lower incidence of major coronary events for patients with atherosclerotic vascular disease receiving intensive statins is linked with use of anacetrapib.
- Loading...
Loading...
Loading... 
Loading...